Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Aug 12, 2014 at 11:44 AM EDT

Short Sellers Vigilant Against Top Biotech Stocks

ThinkstockThe short interest report is out for the July 31 settlement date and 247 Wall St. is focusing on the…

Jon C. Ogg | Aug 11, 2014 at 3:15 PM EDT

Can Tekmira Make Much Money From Its Ebola Treatment?

ThinkstockTekmira Pharmaceuticals Corp. (NASDAQ: TKMR) has made a name for itself pioneering new experimental treatments in the wake of the most…

Lee Jackson | Aug 11, 2014 at 9:34 AM EDT

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

ThinkstockAfter being absolutely rocked back in the spring, the biotech sector has bounced back smartly. Even a bubble comment from…

Jon C. Ogg | Aug 11, 2014 at 9:11 AM EDT

MannKind Secures Future of Afrezza in Major Sanofi Deal

ThinkstockMannKind Corp. (NASDAQ: MNKD) was supposed to be in the news for its earnings report. Instead, we got news of…

Jon C. Ogg | Aug 7, 2014 at 11:05 AM EDT

Thoratec Implodes on Guidance and Revenue Miss

Thoratec was the king of the stock drops in Wednesday's after-hours trading session. We have seen multiple analyst downgrades as…

Lee Jackson | Aug 7, 2014 at 8:20 AM EDT

4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher

We have seen four biotech research reports in which the analysts covering these stocks are now calling for upside of…

Lee Jackson | Aug 5, 2014 at 10:10 AM EDT

5 Affordable Care Act Stock Winners to Buy Now

A new research report from the analysts at Stifel notes that the managed care organizations (MCOs) have posted solid results…

Jon C. Ogg | Aug 4, 2014 at 11:40 AM EDT

Should Investors Really Be Chasing Potential Ebola Treatments?

ThinkstockThe world is dealing with Ebola outbreaks and scares again. We are also in the midst of debates as to…

Jon C. Ogg | Aug 1, 2014 at 10:20 AM EDT

Do Layoffs in Biotech Send the Right Message?

This week's layoff announcement by Amgen may have investors and the public starting to rethink what "being a biotech company"…

Paul Ausick | Jul 29, 2014 at 7:50 AM EDT

Drugmakers Merck, Pfizer Eke Out Profit Hikes

Drug giants Merck and Pfizer reported better-than-expected second-quarter 2014 results before markets opened Tuesday morning.

Paul Ausick | Jul 25, 2014 at 8:40 AM EDT

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie reported better-than-expected second-quarter 2014 results before markets opened Friday morning, due in part to strong sales of its Humira…

Jon C. Ogg | Jul 23, 2014 at 4:41 PM EDT

You Just Won’t Believe Gilead’s Profit Margins

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) has now reported its second-quarter earnings. The largest biotech by market cap turned in earnings…

Jon C. Ogg | Jul 23, 2014 at 11:45 AM EDT

Is Puma Biotech For Real, Again?

Puma Biotechnology has just defied all odds in biotech. The stock has risen more than 200% in a single day,…

Paul Ausick | Jul 21, 2014 at 9:45 AM EDT

Allergan Chops 1,500 Jobs to Fend Off Valeant

Allergan reported better-than-expected second-quarter 2014 results before markets opened Monday morning. The Botox-maker also announced that it will execute a…

Paul Ausick | Jul 21, 2014 at 8:30 AM EDT

Valeant Offer Weaker After Allergan Earnings

In a sharply worded press release Monday morning, Valeant Pharmaceuticals said that it "can no longer tolerate" statements from Allergan…

1 … 283 284 285 286 287 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Vigilant Against Top Biotech Stocks

Can Tekmira Make Much Money From Its Ebola Treatment?

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

MannKind Secures Future of Afrezza in Major Sanofi Deal

Thoratec Implodes on Guidance and Revenue Miss

4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher

5 Affordable Care Act Stock Winners to Buy Now

Should Investors Really Be Chasing Potential Ebola Treatments?

Do Layoffs in Biotech Send the Right Message?

Drugmakers Merck, Pfizer Eke Out Profit Hikes

AbbVie Earnings Take Back Seat to Shire Merger

You Just Won’t Believe Gilead’s Profit Margins

Is Puma Biotech For Real, Again?

Allergan Chops 1,500 Jobs to Fend Off Valeant

Valeant Offer Weaker After Allergan Earnings

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Vigilant Against Top Biotech Stocks

Can Tekmira Make Much Money From Its Ebola Treatment?

New Analyst Biotech Stocks to Buy With Gigantic Implied Upside

MannKind Secures Future of Afrezza in Major Sanofi Deal

Thoratec Implodes on Guidance and Revenue Miss

4 Biotech Stocks Where Analysts See 100% Upside, or Even Higher

5 Affordable Care Act Stock Winners to Buy Now

Should Investors Really Be Chasing Potential Ebola Treatments?

Do Layoffs in Biotech Send the Right Message?

Drugmakers Merck, Pfizer Eke Out Profit Hikes

AbbVie Earnings Take Back Seat to Shire Merger

You Just Won’t Believe Gilead’s Profit Margins

Is Puma Biotech For Real, Again?

Allergan Chops 1,500 Jobs to Fend Off Valeant

Valeant Offer Weaker After Allergan Earnings

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

Featured Reads

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.